StockData
Wave Life Sciences, Inc. logo

Wave Life Sciences, Inc. (WVE) stock

WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3046% below fair value
$2.84−0.03 (-1.05%)

Close on Nov 17, 2026Market cap $560.13MP/E –Yield –

Wave Life Sciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Wave Life Sciences's operating cash flow for the twelve months ending Sep 30, 2026 was -$207.05M. For fiscal 2025 it was -$187.49M. The highest annual figure on record is -$3.55M in fiscal 2013.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$187.49M–
FY2024Dec 31, 2024-$151.03M–
FY2023Dec 31, 2023-$19.43M–
FY2022Dec 31, 2022-$127.78M–
FY2021Dec 31, 2021-$88.99M–
FY2020Dec 31, 2020-$115.98M–
FY2019Dec 31, 2019-$188.23M–
FY2018Dec 31, 2018-$22.86M–
FY2017Dec 31, 2017-$83.67M–
FY2016Dec 31, 2016-$31.93M–
FY2015Dec 31, 2015-$12.53M–
FY2014Dec 31, 2014-$4.43M–
FY2013Dec 31, 2013-$3.55M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$60.14M–
Q2 FY2026Jun 30, 2026-$53.58M–
Q1 FY2026Mar 31, 2026-$59.55M–
Q4 FY2025Dec 31, 2025-$33.78M–
Q3 FY2025Sep 30, 2025-$44.67M–
Q2 FY2025Jun 30, 2025-$46.01M–
Q1 FY2025Mar 31, 2025-$63.04M–
Q4 FY2024Dec 31, 2024-$43.65M–
Q3 FY2024Sep 30, 2024-$46.48M–
Q2 FY2024Jun 30, 2024-$27.47M–
Q1 FY2024Mar 31, 2024-$33.43M-139.1%
Q4 FY2023Dec 31, 2023-$33.24M–
Q3 FY2023Sep 30, 2023-$34.46M–
Q2 FY2023Jun 30, 2023-$37.26M–
Q1 FY2023Mar 31, 2023$85.52M–
Q4 FY2022Dec 31, 2022-$33.44M–
Q3 FY2022Sep 30, 2022-$25.65M–
Q2 FY2022Jun 30, 2022-$28.82M–
Q1 FY2022Mar 31, 2022-$39.87M–
Q4 FY2021Dec 31, 2021-$7.03M–
Q3 FY2021Sep 30, 2021-$28.18M–
Q2 FY2021Jun 30, 2021-$9.40M–
Q1 FY2021Mar 31, 2021-$44.38M–
Q4 FY2020Dec 31, 2020-$31.42M–
Q3 FY2020Sep 30, 2020-$20.17M–
Q2 FY2020Jun 30, 2020-$38.15M–
Q1 FY2020Mar 31, 2020-$26.25M–
Q4 FY2019Dec 31, 2019-$61.24M–
Q3 FY2019Sep 30, 2019-$43.68M–
Q2 FY2019Jun 30, 2019-$32.93M-146.1%
Q1 FY2019Mar 31, 2019-$50.38M–
Q4 FY2018Dec 31, 2018-$32.82M–
Q3 FY2018Sep 30, 2018-$29.01M–
Q2 FY2018Jun 30, 2018$71.39M–
Q1 FY2018Mar 31, 2018-$32.43M–
Q4 FY2017Dec 31, 2017-$22.75M–
Q3 FY2017Sep 30, 2017-$23.41M–
Q2 FY2017Jun 30, 2017-$20.09M–
Q1 FY2017Mar 31, 2017-$17.42M–
Q4 FY2016Dec 31, 2016-$13.35M–

More Wave Life Sciences figures

See a number that looks wrong?